Apogen Biotech

Developing therapies targeting cancer drug resistance and tumor evolution

placeSaint Paul, Minnesota, United States calendar_todayFounded 2014 groups5 employees language apogenbiotech.com

Registered entities

Investor mix

10 investors on record; lead investors include M Ventures.

Investor typeCountShare
Venture capital440%
Other / undisclosed660%
Coming soon